🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

13+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 13 of 13 recruiting trials for “Epstein-Barr virus-positive diffuse large B-cell lymphoma”

EARLY_Phase 1RecruitingNCT07162012 ↗

Safety and Efficacy of Anti-EBV Autologous TCR-T Cell Injection in Relapsed/Refractory EBV-Positive Lymphoma

🏥 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine📍 1 site📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT06846463 ↗

Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+

👨‍⚕️ Bruce Hough, MD, Virginia Commonwealth University📍 1 site📅 Started May 2025View details ↗
Phase 3RecruitingNCT06929624 ↗

A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma

🏥 Suzhou Suncadia Biopharmaceuticals Co., Ltd.📍 2 sites📅 Started Apr 2025View details ↗
Phase 1RecruitingNCT06830031 ↗

Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma

👨‍⚕️ Liang Huang, MD, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences📍 1 site📅 Started Mar 2025View details ↗
RecruitingNCT07198230 ↗

Drug-Eluting Bead-Based Transarterial Chemoembolization (DEB-TACE) as a Local Salvage Therapy for Large Lesions in Relapsed and Refractory Diffuse Large B-Cell Lymphoma

🏥 Ting YANG📍 1 site📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT07254754 ↗

Study to Evaluate the Efficacy of Axicabtagene Ciloleucel in Patients With Late Relapse of Diffuse Large B-Cell Lymphoma

👨‍⚕️ Mariana Bastos-Oreiro, Hospital General Universitario Gregorio Marañón📍 15 sites📅 Started Nov 2024View details ↗
Phase 3RecruitingNCT06522555 ↗

The Efficacy and Safety of Pola-ZR2 Versus ZR2 in the Treatment of Old Patients With de Novo Diffuse Large B-cell Lymphoma

🏥 Ruijin Hospital📍 1 site📅 Started Jul 2024View details ↗
Phase 2RecruitingNCT05934448 ↗

Pembro Plus CAR T-cell Therapy in R/R in PMBCL

👨‍⚕️ Jennifer Crombie, MD, Dana-Farber Cancer Institute📍 2 sites📅 Started Nov 2023View details ↗
Phase 2RecruitingNCT05633615 ↗

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

👨‍⚕️ Brian T Hess, SWOG Cancer Research Network📍 87 sites📅 Started Jun 2023View details ↗
RecruitingNCT05725720 ↗

Role of the Gut Microbiome in the Outcome of Diffuse Large B-Cell Lymphoma Patients Treated With CAR-T Cell Therapy

🏥 University of Bologna📍 1 site📅 Started Mar 2023View details ↗
RecruitingNCT05377307 ↗

Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy

👨‍⚕️ Chen-Lung Lin, MD, Pell Bio-Med Technology Co., Ltd.📍 5 sites📅 Started Dec 2022View details ↗
Phase 2RecruitingNCT05257018 ↗

R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse

👨‍⚕️ Dongmei Ji, doctor, Fudan University📍 2 sites📅 Started Feb 2022View details ↗
Phase 1Enrolling by InvitationNCT04488354 ↗

Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T

🏥 Calibr, a division of Scripps Research📍 8 sites📅 Started Jan 2021View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →